Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 12:24 AM UTC
| NCT Number | NCT04938817 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 110 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | June 1, 2026 (Yesterday) |
As of June 2, 2026: Clinical trial NCT04938817 is currently active_not_recruiting participants. This clinical trial study for small cell lung cancer is not currently accepting new participants at 12 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04938817 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04938817 was last updated Yesterday (June 1, 2026). HelloStudys verifies this status automatically.